Cefotaxime-sensitive Aeromonas hydrophila infection in a revascularized foot.
Three days following revascularization of a foot injured in a boating accident, Aeromonas hydrophila cellulitis developed in the victim's foot and leg. The infection resolved with debridement and 10 days of cefotaxime therapy. A. hydrophila infection has not previously been reported in a revascularized extremity. Clinical response of an A. hydrophila cellulitis to cefotaxime is likewise undescribed. Our findings of a cefotaxime-sensitive Aeromonas infection and its successful treatment suggests that the organism should undergo further evaluation of cefotaxime sensitivity and that cefotaxime and other third-generation cephalosporins may have a role as broad-spectrum antibiotic agents in fresh-water trauma.
D000328:Adult; D000333:Aeromonas / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000627:therapeutic use*; D002481:Cellulitis / Q000188:drug therapy* / Q000209:etiology; D005528:Foot / Q000098:blood supply / Q000601:surgery; D018409:Foot Injuries; D006801:Humans; D008297:Male; D016038:Skin Transplantation; D014680:Veins / Q000637:transplantation; D014950:Wounds, Penetrating / Q000601:surgery
D002439:Cefotaxime